Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 474

1.

Buprenorphine Prescribing: To Expand or Not to Expand.

Li X, Shorter D, Kosten TR.

J Psychiatr Pract. 2016 May;22(3):183-92. doi: 10.1097/PRA.0000000000000154.

PMID:
27123798
2.

Smoking and Serum Lipid Profiles in Schizophrenia.

An HM, Tan YL, Tan SP, Shi J, Wang ZR, Yang FD, Huang XF, Soars JC, Kosten TR, Zhang XY.

Neurosci Bull. 2016 Mar 28. [Epub ahead of print]

PMID:
27017941
3.

Serum IL-18 level, clinical symptoms and IL-18-607A/C polymorphism among chronic patients with schizophrenia in a Chinese Han population.

Zhang XY, Tan YL, Chen DC, Tan SP, Malouta MZ, Bernard JD, Combs JL, Bhatti S, Davis MC, Kosten TR, Soares JC.

Psychoneuroendocrinology. 2016 Jun;68:140-147. doi: 10.1016/j.psyneuen.2016.03.002. Epub 2016 Mar 5.

PMID:
26974498
4.

Contribution of IL-10 and its -592 A/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia.

Xiu MH, Tian L, Chen S, Tan YL, Chen DC, Chen J, Chen N, De Yang F, Licinio J, Kosten TR, Soares JC, Zhang XY.

Brain Behav Immun. 2016 Mar 10. pii: S0889-1591(16)30050-2. doi: 10.1016/j.bbi.2016.03.005. [Epub ahead of print]

PMID:
26971470
5.

Next Generation Programmable Bio-Nano-Chip System for On-Site Detection in Oral Fluids.

Christodoulides N, De La Garza R 2nd, Simmons GW, McRae MP, Wong J, Newton TF, Kosten TR, Haque A, McDevitt JT.

J Drug Abuse. 2015 Nov 23;1(1):1-6.

6.

Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study.

Zhang XY, Fan FM, Chen DC, Tan YL, Tan SP, Hu K, Salas R, Kosten TR, Zunta-Soares G, Soares JC.

J Clin Psychiatry. 2016 Feb;77(2):205-11. doi: 10.4088/JCP.14m09374.

PMID:
26761708
7.

Pharmacologic management of comorbid post-traumatic stress disorder and addictions.

Shorter D, Hsieh J, Kosten TR.

Am J Addict. 2015 Dec;24(8):705-12. doi: 10.1111/ajad.12306. Epub 2015 Nov 20. Review.

PMID:
26587796
8.

Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine.

Haile CN, Kosten TA, Shen XY, O'Malley PW, Winoske KJ, Kinsey BM, Wu Y, Huang Z, Lykissa ED, Naidu N, Cox JA, Arora R, Kosten TR, Orson FM.

Am J Addict. 2015 Dec;24(8):748-55. doi: 10.1111/ajad.12307. Epub 2015 Nov 19.

PMID:
26584468
9.

Beneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms.

An HM, Tan YL, Shi J, Wang ZR, Li J, Wang YC, Lv MH, Zhou DF, Soares JC, Kosten TR, Yang FD, Zhang XY.

Behav Brain Res. 2016 Jan 15;297:124-30. doi: 10.1016/j.bbr.2015.10.004. Epub 2015 Oct 9.

PMID:
26455874
10.

Interaction of BDNF with cytokines in chronic schizophrenia.

Zhang XY, Tan YL, Chen DC, Tan SP, Yang FD, Wu HE, Zunta-Soares GB, Huang XF, Kosten TR, Soares JC.

Brain Behav Immun. 2016 Jan;51:169-75. doi: 10.1016/j.bbi.2015.09.014. Epub 2015 Sep 25.

PMID:
26407757
11.

Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans.

Newton TF, Haile CN, Mahoney JJ 3rd, Shah R, Verrico CD, De La Garza R 2nd, Kosten TR.

Psychiatry Res. 2015 Nov 30;230(1):44-9. doi: 10.1016/j.psychres.2015.07.073. Epub 2015 Jul 29.

PMID:
26239766
12.

Inhibitory behavioral control: A stochastic dynamic causal modeling study comparing cocaine dependent subjects and controls.

Ma L, Steinberg JL, Cunningham KA, Lane SD, Bjork JM, Neelakantan H, Price AE, Narayana PA, Kosten TR, Bechara A, Moeller FG.

Neuroimage Clin. 2015 Mar 24;7:837-47. doi: 10.1016/j.nicl.2015.03.015. eCollection 2015.

13.

Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids.

Christodoulides N, De La Garza R 2nd, Simmons GW, McRae MP, Wong J, Newton TF, Smith R, Mahoney Iii JJ, Hohenstein J, Gomez S, Floriano PN, Talavera H, Sloan DJ, Moody DE, Andrenyak DM, Kosten TR, Haque A, McDevitt JT.

Drug Alcohol Depend. 2015 Aug 1;153:306-13. doi: 10.1016/j.drugalcdep.2015.04.026. Epub 2015 May 22.

PMID:
26048639
14.

Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.

Brewer AJ 3rd, Nielsen DA, Spellicy CJ, Hamon SC, Gingrich J, Thompson-Lake DG, Nielsen EM, Mahoney JJ 3rd, Kosten TR, Newton TF, De La Garza R 2nd.

Pharmacogenet Genomics. 2015 Jun;25(6):296-304. doi: 10.1097/FPC.0000000000000137.

PMID:
25850966
15.

ZNF804A variants confer risk for heroin addiction and affect decision making and gray matter volume in heroin abusers.

Sun Y, Zhao LY, Wang GB, Yue WH, He Y, Shu N, Lin QX, Wang F, Li JL, Chen N, Wang HM, Kosten TR, Feng JJ, Wang J, Tang YD, Liu SX, Deng GF, Diao GH, Tan YL, Han HB, Lin L, Shi J.

Addict Biol. 2016 May;21(3):657-66. doi: 10.1111/adb.12233. Epub 2015 Feb 24.

PMID:
25708696
16.

A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic.

Buda JJ, Carroll FI, Kosten TR, Swearingen D, Walters BB.

Neuropsychopharmacology. 2015 Aug;40(9):2059-65. doi: 10.1038/npp.2015.27. Epub 2015 Jan 23.

17.

Reinforcement sensitivity underlying treatment-seeking smokers' affect, smoking reinforcement motives, and affective responses.

Cui Y, Robinson JD, Engelmann JM, Lam CY, Minnix JA, Karam-Hage M, Wetter DW, Dani JA, Kosten TR, Cinciripini PM.

Psychol Addict Behav. 2015 Jun;29(2):300-11. doi: 10.1037/adb0000050. Epub 2015 Jan 26.

PMID:
25621416
18.

A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats.

Li QQ, Sun CY, Luo YX, Xue YX, Meng SQ, Xu LZ, Chen N, Deng JH, Zhai HF, Kosten TR, Shi J, Lu L, Sun HQ.

Int J Neuropsychopharmacol. 2014 Dec 7;18(5). pii: pyu093. doi: 10.1093/ijnp/pyu093.

19.

Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers.

Thompson-Lake DG, Cooper KN, Mahoney JJ 3rd, Bordnick PS, Salas R, Kosten TR, Dani JA, De La Garza R 2nd.

Nicotine Tob Res. 2015 Jul;17(7):796-802. doi: 10.1093/ntr/ntu245. Epub 2014 Dec 4.

PMID:
25475087
20.

Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy.

Shorter D, Domingo CB, Kosten TR.

Expert Opin Emerg Drugs. 2015 Mar;20(1):15-29. doi: 10.1517/14728214.2015.985203. Epub 2014 Nov 26. Review.

PMID:
25425416
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk